Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Earnings Peek: Arrowhead Research Corporation's Focus Is On The Clinical Hold

Arrowhead Research Corporation (NASDAQ:ARWR) is a small biopharmaceutical company (market cap of $336.30 million) developing therapeutics that target RNA interference ((RNAi)), a mechanism that efficiently silences disease causing genes. Arrowhead's platform technologies also enable partners to create peptide drug Dynamic Polyconjugates and Homing Peptides that provide delivery systems to nearly every cell and tissue types of interest while sparing off-target tissues. Arrowhead will report its financial results for the fiscal first quarter (FQ1) 2015 ended December 31, 2014, on February 9, 2015 after the bell. Of particular interest in Q1 will be the letter from the U.S. Food and Drug Administration (FDA) detailing its thoughts and requests by February 11. The FDA had verbally informed Arrowhead of a partial clinical hold on the company's lead…